On April 18, 2025, Mind Medicine (MindMed) Inc. amended its loan agreement to secure up to $120 million in term loans, with a portion used to refinance existing loans and a conversion option for lenders to convert up to $7 million into common shares at prices between $4.01 and $9.00. The loans mature on April 1, 2029, and are secured by the company's assets, excluding intellectual property.